Abstract:The original synthesis of dopamine in the laboratories of H.E. Dale in South London, followed some 50 years later by the seminal mapping of the mesencephalic dopamine (DA) pathways into ramifying mesostriatal, mesolimbic and mesocortical projections, the identification of several DA receptors and their signalling pathways, and the discovery of phasic and tonic modes of dopaminergic activity, have led to important questions about the functions of this modulatory neurotransmitter. The triadic division of these projections has suggested discrete and even parallel functions in movement (eg, Parkinson9s disease, dorsal striatum), reward (eg, drugs of abuse, nucleus accumbens) and cognition (eg, schizophrenia and attention deficit/hyperactivity disorder (ADHD), prefrontal cortex). However, several lines of evidence show that this division to be artificial, it also being important to consider interactions between prefrontal and striatal systems, between the various sectors of the striatum itself, and even its component “direct” and “indirect” pathways. This lecture will provide several examples of how work performed in experimental animals has informed these functional considerations, while also having profound implications for understanding the functions of dopamine in health and disease. A prime example is the discovery that prefrontal cortical dopamine modulates cognitive functions such as working memory, which our own work has suggested to be a consequence of stabilising representations of the world via dopamine D1 receptor actions. This contrasts with findings that striatal dopamine often serves to promote behavioural switching, as occurs for example in Parkinson9s disease, ADHD and stimulant abuse following dopaminergic therapy with l-dopa, methylphenidate, and a D2/3 agonist, respectively. The hypothesis that there exist optimal levels of dopamine activity for efficient cognitive functioning in the prefrontal cortex also has applicability in the sub-cortical brain, based for example on the discovery that optimal titration of dopaminergic therapy for motor function in Parkinson9s disease can lead, not only to cognitive enhancement, but also behavioural dysregulation in certain domains, possibly arising as a consequence of an “over-dosing” of ventral striatal dopamine pathways with probable motivational consequences. Such a motivational role is consonant with the discovery that rewarding effects of psychomotor stimulant drugs such as cocaine and amphetamine were mediated by dopamine-dependent functions of the nucleus accumbens in rats. Recent work has shown that addiction to such drugs is predicted by individual differences in the propensity for impulsive behaviour, associated with variations in dopamine receptor number in the ventral striatum. This impulsivity may reflect an aberrant engagement of pavlovian approach behaviour. However, work in animals has suggested that during the addictive process, there is a shift in control of drug-seeking behaviour from the ventral to dorsal striatum that is consistent with a role for dopamine in stimulus-response habit learning. Implications for recent findings in chronic drug abusers will also be discussed.

Heterogeneous dopamine signals support distinct features of motivated actions: implications for learning and addiction

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use

A Concurrent Excitation and Inhibition of Dopaminergic Subpopulations in Response to Nicotine

Associative Processes in Addiction and Reward the Role of Amygdala‐Ventral Striatal Subsystems

Dopamine, behavior, and addiction

Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse

Associative Processes in Addiction and Reward The Role of Amygdala-Ventral Striatal Subsystems

GL.01 Dopamine in Health and Disease

Dopamine signaling in the dorsomedial striatum promotes compulsive behavior

Ventral pallidum DRD3 potentiates a pallido-habenular circuit driving accumbal dopamine release and cocaine seeking

Compulsive Drug-Taking is Associated with Habenula–frontal Cortex Connectivity

Compulsive Drug Use is Associated with Imbalance of Orbitofrontal- and Prelimbic-Striatal Circuits in Punishment-Resistant Individuals

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction

Interaction of the Dopaminergic System with Mechanisms of Associative Learning and Cognition: Implications for Drug Abuse

The ins and outs of the striatum: Role in drug addiction

Phasic Mesolimbic Dopamine Signaling Encodes the Facilitation of Incentive Motivation Produced by Repeated Cocaine Exposure

An Insight into the Cellular Mechanisms of Addiction to Psychostimulants

Targeting Neuroplasticity in Substance Use Disorders: Implications for Therapeutics

Parallel and Interactive Learning Processes Within the Basal Ganglia: Relevance for the Understanding of Addiction

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease